These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1650514)

  • 1. Prevalence of anti-hepatitis C virus seroconversion in polytransfused thalassemic patients.
    Borzini P; Cazzaniga G; Vecchi L
    Vox Sang; 1991; 60(3):188. PubMed ID: 1650514
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody to hepatitis C virus in thalassemia patients.
    Isahak I; Baharin R; Hakim AS; Abu Bakar M; George E
    Malays J Pathol; 1993 Jun; 15(1):85-7. PubMed ID: 8277796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C virus antibody in beta-thalassemic polytransfused children in a long-term follow-up.
    Resti M; Azzari C; Rossi ME; Vullo C; Borgatti L; Vierucci A
    Vox Sang; 1991; 60(4):246-7. PubMed ID: 1926834
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis G virus or hepatitis GB virus type C infection in thalassemic patients.
    Papaevangelou V; Spanou E; Kattamis C; Hadziyannis S
    Transfusion; 1999 Mar; 39(3):336-7. PubMed ID: 10204602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-HCV antibodies and post-transfusional non-A, non-B hepatitis].
    Smilovici W; Trepo C; Marinière AM; Ducos J
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):359-60. PubMed ID: 2177599
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil.
    Watanabe MA; Milanezi CM; Silva WA; de Lucena Angulo I; Santis G; Kashima S; da Costa JA; Neto MM; Covas DT
    Ren Fail; 2003 Jan; 25(1):67-75. PubMed ID: 12617334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
    Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
    Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of hepatitis A antibodies in polytransfused thalassemic patients].
    Mangiagli A
    Pediatr Med Chir; 1997; 19(6):437-8. PubMed ID: 9595581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first- and second-generation assay.
    Lai ME; De Virgilis S; Argiolu F; Farci P; Mazzoleni AP; Lisci V; Rapicetta M; Clemente MG; Nurchis P; Arnone M
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):458-64. PubMed ID: 7686220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
    Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
    Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to hepatitis C virus in post-transfusion hepatitis.
    Tremolada F; Casarin C; Tagger A; Ribero ML; Realdi G; Alberti A; Ruol A
    Ann Intern Med; 1991 Feb; 114(4):277-81. PubMed ID: 1846277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 20. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.